Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Extranodal NK-T-Cell × Bendamustine Hydrochloride × 90 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 10 Lymphoma, Follicular 8 Lymphoma 8 Lymphoma, Mantle-Cell 5 Neoplasms 3 Lymphoma, Non-Hodgkin 3 Lymphoma, Large B-Cell, Diffuse 3 Lymphoma, B-Cell 3 Recurrence 2 Lymphoma, B-Cell, Marginal Zone 2 Leukemia 2 Hodgkin Disease 2 Waldenstrom Macroglobulinemia 1 Sezary Syndrome 1 Precursor B-Cell Lymphoblastic Leukemia-Lymphoma 1 Ovarian Neoplasms 1 Mycosis Fungoides 1 Multiple Myeloma 1 Lymphoproliferative Disorders 1 Lymphomatoid Papulosis 1 Lymphoma, T-Cell, Peripheral 1 Lymphoma, T-Cell, Cutaneous 1 Lymphoma, T-Cell 1 Lymphatic Diseases 1 Immunoproliferative Disorders 1 Immunoblastic Lymphadenopathy 1 Immune System Diseases 1 Hematopoietic and Lymphoid System Neoplasm 1 Hematologic Diseases 1 Fallopian Tube Neoplasms 1

Interventions

pegaspargase 3 tislelizumab 1 sugemalimab 1 relatlimab 1 gemcitabine-oxaliplatin regimen 1 Vorinostat 1 Valganciclovir 1 Therapeutics 1 Polymerase Chain Reaction 1 Oxaliplatin 1 Nivolumab 1 Immune Checkpoint Inhibitors 1 Ice 1 Gemcitabine 1 Ganciclovir 1 Foscarnet 1 Flow Cytometry 1 Cholecalciferol 1 Azacitidine 1 Antiviral Agents 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡